25 XP   0   0   10

Insulet Corporation
Buy, Hold or Sell?

Let's analyse Insulet together

PenkeI guess you are interested in Insulet Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Insulet Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Insulet Corporation

I send you an email if I find something interesting about Insulet Corporation.

Quick analysis of Insulet (30 sec.)










What can you expect buying and holding a share of Insulet? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€9.62
Expected worth in 1 year
€12.99
How sure are you?
75.9%

+ What do you gain per year?

Total Gains per Share
€3.37
Return On Investment
2.0%

For what price can you sell your share?

Current Price per Share
€169.15
Expected price per share
€121.15 - €182.60
How sure are you?
50%

1. Valuation of Insulet (5 min.)




Live pricePrice per Share (EOD)

€169.15

Intrinsic Value Per Share

€45.22 - €54.86

Total Value Per Share

€54.84 - €64.48

2. Growth of Insulet (5 min.)




Is Insulet growing?

Current yearPrevious yearGrowGrow %
How rich?$732.6m$443.3m$155.8m26.0%

How much money is Insulet making?

Current yearPrevious yearGrowGrow %
Making money$51.5m$1.1m$50.4m97.8%
Net Profit Margin11.4%0.2%--

How much money comes from the company's main activities?

3. Financial Health of Insulet (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#45 / 335

Most Revenue
#32 / 335

Most Profit
#23 / 335

What can you expect buying and holding a share of Insulet? (5 min.)

Welcome investor! Insulet's management wants to use your money to grow the business. In return you get a share of Insulet.

What can you expect buying and holding a share of Insulet?

First you should know what it really means to hold a share of Insulet. And how you can make/lose money.

Speculation

The Price per Share of Insulet is €169.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Insulet.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Insulet, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €9.62. Based on the TTM, the Book Value Change Per Share is €0.84 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Insulet.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps1.480.9%0.750.4%0.020.0%0.160.1%0.090.1%
Usd Book Value Change Per Share1.791.1%0.920.5%-0.29-0.2%0.370.2%0.360.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.791.1%0.920.5%-0.29-0.2%0.370.2%0.360.2%
Usd Price Per Share213.00-245.61-260.53-219.51-171.04-
Price to Earnings Ratio36.10-119.92--124.39-242.70-144.54-
Price-to-Total Gains Ratio119.13-392.86-698.61-316.48-641.12-
Price to Book Ratio20.36-29.97-41.06-49.62-45.90-
Price-to-Total Gains Ratio119.13-392.86-698.61-316.48-641.12-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share183.916795
Number of shares5
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.920.37
Usd Total Gains Per Share0.920.37
Gains per Quarter (5 shares)4.581.86
Gains per Year (5 shares)18.307.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1018807-3
2037260154
30554402211
40736203018
50928003725
601109804532
7012811605239
8014613405946
9016515206753
10018317007460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%8.04.00.066.7%14.06.00.070.0%16.013.00.055.2%16.013.00.055.2%
Book Value Change Per Share4.00.00.0100.0%8.04.00.066.7%13.07.00.065.0%22.07.00.075.9%22.07.00.075.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.029.00.0%0.00.029.00.0%
Total Gains per Share4.00.00.0100.0%8.04.00.066.7%13.07.00.065.0%22.07.00.075.9%22.07.00.075.9%

Fundamentals of Insulet

About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-28 17:13:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Insulet Corporation.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Insulet earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Insulet to the Medical Devices industry mean.
  • A Net Profit Margin of 20.3% means that €0.20 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Insulet Corporation:

  • The MRQ is 20.3%. The company is making a huge profit. +2
  • The TTM is 11.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ20.3%TTM11.4%+8.8%
TTM11.4%YOY0.2%+11.2%
TTM11.4%5Y3.0%+8.4%
5Y3.0%10Y1.0%+2.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ20.3%-10.8%+31.1%
TTM11.4%-17.8%+29.2%
YOY0.2%-13.1%+13.3%
5Y3.0%-20.1%+23.1%
10Y1.0%-25.0%+26.0%
1.1.2. Return on Assets

Shows how efficient Insulet is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Insulet to the Medical Devices industry mean.
  • 4.0% Return on Assets means that Insulet generated €0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Insulet Corporation:

  • The MRQ is 4.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.0%TTM2.1%+1.9%
TTM2.1%YOY0.1%+2.0%
TTM2.1%5Y0.5%+1.5%
5Y0.5%10Y0.1%+0.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0%-3.6%+7.6%
TTM2.1%-4.2%+6.3%
YOY0.1%-3.9%+4.0%
5Y0.5%-3.8%+4.3%
10Y0.1%-4.3%+4.4%
1.1.3. Return on Equity

Shows how efficient Insulet is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Insulet to the Medical Devices industry mean.
  • 14.1% Return on Equity means Insulet generated €0.14 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Insulet Corporation:

  • The MRQ is 14.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 8.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.1%TTM8.1%+6.0%
TTM8.1%YOY0.1%+8.0%
TTM8.1%5Y2.1%+5.9%
5Y2.1%10Y-0.2%+2.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ14.1%-3.6%+17.7%
TTM8.1%-4.7%+12.8%
YOY0.1%-4.6%+4.7%
5Y2.1%-5.6%+7.7%
10Y-0.2%-5.7%+5.5%

1.2. Operating Efficiency of Insulet Corporation.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Insulet is operating .

  • Measures how much profit Insulet makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Insulet to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Insulet Corporation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.9%-1.9%
TTM1.9%YOY4.5%-2.6%
TTM1.9%5Y7.2%-5.3%
5Y7.2%10Y5.5%+1.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--26.3%+26.3%
TTM1.9%-13.8%+15.7%
YOY4.5%-13.8%+18.3%
5Y7.2%-18.9%+26.1%
10Y5.5%-24.4%+29.9%
1.2.2. Operating Ratio

Measures how efficient Insulet is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.08 means that the operating costs are €1.08 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Insulet Corporation:

  • The MRQ is 1.083. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.196. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.083TTM1.196-0.113
TTM1.196YOY1.351-0.155
TTM1.1965Y1.266-0.071
5Y1.26610Y1.224+0.042
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0831.429-0.346
TTM1.1961.431-0.235
YOY1.3511.392-0.041
5Y1.2661.413-0.147
10Y1.2241.375-0.151

1.3. Liquidity of Insulet Corporation.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Insulet is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.51 means the company has €3.51 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Insulet Corporation:

  • The MRQ is 3.508. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.395. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.508TTM3.395+0.113
TTM3.395YOY4.561-1.166
TTM3.3955Y5.017-1.622
5Y5.01710Y5.287-0.270
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5082.694+0.814
TTM3.3952.732+0.663
YOY4.5613.418+1.143
5Y5.0173.658+1.359
10Y5.2873.632+1.655
1.3.2. Quick Ratio

Measures if Insulet is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Insulet to the Medical Devices industry mean.
  • A Quick Ratio of 0.80 means the company can pay off €0.80 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Insulet Corporation:

  • The MRQ is 0.797. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.638. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.797TTM0.638+0.159
TTM0.638YOY0.697-0.059
TTM0.6385Y1.012-0.374
5Y1.01210Y1.707-0.695
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7971.503-0.706
TTM0.6381.557-0.919
YOY0.6972.102-1.405
5Y1.0122.336-1.324
10Y1.7072.596-0.889

1.4. Solvency of Insulet Corporation.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Insulet assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Insulet to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.72 means that Insulet assets are financed with 71.7% credit (debt) and the remaining percentage (100% - 71.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Insulet Corporation:

  • The MRQ is 0.717. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.755. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.717TTM0.755-0.038
TTM0.755YOY0.794-0.039
TTM0.7555Y0.769-0.014
5Y0.76910Y0.784-0.015
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7170.414+0.303
TTM0.7550.399+0.356
YOY0.7940.335+0.459
5Y0.7690.441+0.328
10Y0.7840.454+0.330
1.4.2. Debt to Equity Ratio

Measures if Insulet is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Insulet to the Medical Devices industry mean.
  • A Debt to Equity ratio of 253.2% means that company has €2.53 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Insulet Corporation:

  • The MRQ is 2.532. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.114. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.532TTM3.114-0.581
TTM3.114YOY3.856-0.742
TTM3.1145Y4.511-1.397
5Y4.51110Y4.580-0.070
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5320.596+1.936
TTM3.1140.601+2.513
YOY3.8560.487+3.369
5Y4.5110.637+3.874
10Y4.5800.682+3.898

2. Market Valuation of Insulet Corporation

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Insulet generates.

  • Above 15 is considered overpriced but always compare Insulet to the Medical Devices industry mean.
  • A PE ratio of 36.10 means the investor is paying €36.10 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Insulet Corporation:

  • The EOD is 31.168. Based on the earnings, the company is overpriced. -1
  • The MRQ is 36.097. Based on the earnings, the company is overpriced. -1
  • The TTM is 119.916. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD31.168MRQ36.097-4.929
MRQ36.097TTM119.916-83.820
TTM119.916YOY-124.393+244.309
TTM119.9165Y242.703-122.787
5Y242.70310Y144.537+98.165
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD31.168-1.091+32.259
MRQ36.097-1.633+37.730
TTM119.916-2.226+122.142
YOY-124.393-2.685-121.708
5Y242.703-2.410+245.113
10Y144.537-2.042+146.579
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Insulet Corporation:

  • The EOD is 236.736. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 274.174. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 100.284. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD236.736MRQ274.174-37.438
MRQ274.174TTM100.284+173.890
TTM100.284YOY135.922-35.638
TTM100.2845Y96.332+3.952
5Y96.33210Y66.436+29.896
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD236.736-1.979+238.715
MRQ274.174-3.111+277.285
TTM100.284-2.997+103.281
YOY135.922-5.779+141.701
5Y96.332-5.345+101.677
10Y66.436-5.716+72.152
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Insulet is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 20.36 means the investor is paying €20.36 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Insulet Corporation:

  • The EOD is 17.577. Based on the equity, the company is expensive. -2
  • The MRQ is 20.356. Based on the equity, the company is expensive. -2
  • The TTM is 29.973. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD17.577MRQ20.356-2.780
MRQ20.356TTM29.973-9.616
TTM29.973YOY41.056-11.083
TTM29.9735Y49.616-19.643
5Y49.61610Y45.904+3.712
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD17.5772.128+15.449
MRQ20.3562.373+17.983
TTM29.9732.549+27.424
YOY41.0562.943+38.113
5Y49.6164.024+45.592
10Y45.9044.538+41.366
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Insulet Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.6440.842+95%-0.262+116%0.342+381%0.332+396%
Book Value Per Share--9.6247.870+22%5.823+65%5.772+67%4.517+113%
Current Ratio--3.5083.395+3%4.561-23%5.017-30%5.287-34%
Debt To Asset Ratio--0.7170.755-5%0.794-10%0.769-7%0.784-9%
Debt To Equity Ratio--2.5323.114-19%3.856-34%4.511-44%4.580-45%
Dividend Per Share----0%-0%-0%-0%
Eps--1.3570.689+97%0.015+8883%0.147+820%0.087+1461%
Free Cash Flow Per Share--0.1790.120+49%-0.126+170%-0.226+226%-0.226+226%
Free Cash Flow To Equity Per Share--0.2080.075+176%-0.258+224%0.260-20%0.260-20%
Gross Profit Margin--1.0001.0000%1.0000%0.950+5%0.966+4%
Intrinsic Value_10Y_max--54.858--------
Intrinsic Value_10Y_min--45.221--------
Intrinsic Value_1Y_max--0.075--------
Intrinsic Value_1Y_min--0.070--------
Intrinsic Value_3Y_max--4.357--------
Intrinsic Value_3Y_min--4.076--------
Intrinsic Value_5Y_max--13.621--------
Intrinsic Value_5Y_min--12.287--------
Market Cap11844305198.400-16%13717406966.40015817206565.200-13%16778265322.800-18%14136631649.952-3%11014734200.875+25%
Net Profit Margin--0.2030.114+77%0.002+10115%0.030+566%0.010+1965%
Operating Margin---0.019-100%0.045-100%0.072-100%0.055-100%
Operating Ratio--1.0831.196-9%1.351-20%1.266-14%1.224-12%
Pb Ratio17.577-16%20.35629.973-32%41.056-50%49.616-59%45.904-56%
Pe Ratio31.168-16%36.097119.916-70%-124.393+445%242.703-85%144.537-75%
Price Per Share169.150-16%195.900225.888-13%239.613-18%201.887-3%157.303+25%
Price To Free Cash Flow Ratio236.736-16%274.174100.284+173%135.922+102%96.332+185%66.436+313%
Price To Total Gains Ratio102.863-16%119.130392.864-70%698.608-83%316.476-62%641.116-81%
Quick Ratio--0.7970.638+25%0.697+14%1.012-21%1.707-53%
Return On Assets--0.0400.021+93%0.001+7773%0.005+639%0.001+2909%
Return On Equity--0.1410.081+75%0.001+19286%0.021+561%-0.002+101%
Total Gains Per Share--1.6440.842+95%-0.262+116%0.342+381%0.332+396%
Usd Book Value--732692533.787599218893.897+22%443370482.009+65%439484421.608+67%343918978.189+113%
Usd Book Value Change Per Share--1.7880.915+95%-0.285+116%0.372+381%0.361+396%
Usd Book Value Per Share--10.4648.558+22%6.332+65%6.276+67%4.912+113%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--1.4750.749+97%0.016+8883%0.160+820%0.095+1461%
Usd Free Cash Flow--13599861.4169124907.016+49%-9574902.431+170%-13754859.837+201%-9486110.232+170%
Usd Free Cash Flow Per Share--0.1940.130+49%-0.137+170%-0.246+226%-0.246+226%
Usd Free Cash Flow To Equity Per Share--0.2260.082+176%-0.281+224%0.283-20%0.283-20%
Usd Market Cap12878313042.220-16%14914936594.56717198048698.342-13%18243007885.480-18%15370759592.993-3%11976320496.611+25%
Usd Price Per Share183.917-16%213.002245.607-13%260.531-18%219.512-3%171.035+25%
Usd Profit--103298947.37351574474.451+100%1149988.282+8883%12304874.612+739%7359993.966+1304%
Usd Revenue--509794805.138424270676.638+20%326321674.748+56%287187073.534+78%237065377.383+115%
Usd Total Gains Per Share--1.7880.915+95%-0.285+116%0.372+381%0.361+396%
 EOD+4 -4MRQTTM+27 -6YOY+25 -85Y+24 -1010Y+26 -8

3.2. Fundamental Score

Let's check the fundamental score of Insulet Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1531.168
Price to Book Ratio (EOD)Between0-117.577
Net Profit Margin (MRQ)Greater than00.203
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.797
Current Ratio (MRQ)Greater than13.508
Debt to Asset Ratio (MRQ)Less than10.717
Debt to Equity Ratio (MRQ)Less than12.532
Return on Equity (MRQ)Greater than0.150.141
Return on Assets (MRQ)Greater than0.050.040
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Insulet Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose169.900
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets2,588,200
Total Liabilities1,855,500
Total Stockholder Equity732,700
 As reported
Total Liabilities 1,855,500
Total Stockholder Equity+ 732,700
Total Assets = 2,588,200

Assets

Total Assets2,588,200
Total Current Assets1,582,900
Long-term Assets1,005,300
Total Current Assets
Cash And Cash Equivalents 704,200
Net Receivables 359,700
Inventory 402,600
Other Current Assets 116,400
Total Current Assets  (as reported)1,582,900
Total Current Assets  (calculated)1,582,900
+/-0
Long-term Assets
Property Plant Equipment 664,900
Goodwill 51,700
Intangible Assets 98,700
Long-term Assets Other 190,000
Long-term Assets  (as reported)1,005,300
Long-term Assets  (calculated)1,005,300
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities451,200
Long-term Liabilities1,404,300
Total Stockholder Equity732,700
Total Current Liabilities
Short Long Term Debt 49,400
Accounts payable 19,200
Other Current Liabilities 68,800
Total Current Liabilities  (as reported)451,200
Total Current Liabilities  (calculated)137,400
+/- 313,800
Long-term Liabilities
Long term Debt 1,366,400
Long-term Liabilities Other 37,900
Long-term Liabilities  (as reported)1,404,300
Long-term Liabilities  (calculated)1,404,300
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)732,700
Total Stockholder Equity (calculated)0
+/- 732,700
Other
Capital Stock100
Common Stock Shares Outstanding 69,907
Net Debt 711,600
Net Invested Capital 2,148,500
Net Working Capital 1,131,700
Property Plant and Equipment Gross 958,100



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
456,647
444,957
459,327
500,348
816,744
829,763
838,856
886,306
928,744
952,612
977,723
1,268,390
1,142,900
1,108,200
1,626,700
1,710,600
1,872,900
1,840,100
1,923,700
1,998,900
2,048,800
2,069,200
2,113,700
2,166,200
2,251,100
2,289,100
2,385,800
2,467,700
2,588,200
2,588,2002,467,7002,385,8002,289,1002,251,1002,166,2002,113,7002,069,2002,048,8001,998,9001,923,7001,840,1001,872,9001,710,6001,626,7001,108,2001,142,9001,268,390977,723952,612928,744886,306838,856829,763816,744500,348459,327444,957456,647
   > Total Current Assets 
369,960
337,168
338,745
366,020
537,171
451,611
421,793
445,712
461,286
496,382
498,807
793,901
591,000
541,300
1,085,700
1,160,400
1,248,700
1,191,800
1,252,900
1,306,900
1,329,800
1,285,400
1,309,100
1,329,100
1,314,000
1,330,000
1,421,500
1,471,100
1,582,900
1,582,9001,471,1001,421,5001,330,0001,314,0001,329,1001,309,1001,285,4001,329,8001,306,9001,252,9001,191,8001,248,7001,160,4001,085,700541,300591,000793,901498,807496,382461,286445,712421,793451,611537,171366,020338,745337,168369,960
       Cash And Cash Equivalents 
137,174
76,038
73,488
102,233
272,577
203,146
136,246
126,563
113,906
129,254
119,867
419,882
213,700
198,500
776,200
834,300
907,200
817,900
851,800
853,700
791,600
708,500
707,400
721,500
674,700
620,700
660,100
669,800
704,200
704,200669,800660,100620,700674,700721,500707,400708,500791,600853,700851,800817,900907,200834,300776,200198,500213,700419,882119,867129,254113,906126,563136,246203,146272,577102,23373,48876,038137,174
       Short-term Investments 
161,396
177,990
185,117
173,523
167,479
148,853
163,546
163,281
175,040
187,120
189,881
185,622
162,400
120,200
65,300
58,600
40,400
29,500
17,500
500
0
0
0
0
0
0
0
0
0
00000000050017,50029,50040,40058,60065,300120,200162,400185,622189,881187,120175,040163,281163,546148,853167,479173,523185,117177,990161,396
       Net Receivables 
28,803
40,648
37,753
47,173
53,373
55,829
63,634
79,913
76,672
68,655
66,958
65,052
82,800
80,100
78,000
85,400
83,800
97,900
100,300
114,300
161,000
189,300
206,600
201,400
205,600
217,200
250,500
270,300
359,700
359,700270,300250,500217,200205,600201,400206,600189,300161,000114,300100,30097,90083,80085,40078,00080,10082,80065,05266,95868,65576,67279,91363,63455,82953,37347,17337,75340,64828,803
       Inventory 
35,514
34,333
33,956
35,054
33,793
26,334
40,808
58,050
71,414
73,822
85,109
90,207
101,000
95,700
103,700
124,900
154,300
170,100
197,800
259,000
303,200
314,800
320,400
327,600
346,800
386,100
411,300
410,800
402,600
402,600410,800411,300386,100346,800327,600320,400314,800303,200259,000197,800170,100154,300124,900103,70095,700101,00090,20785,10973,82271,41458,05040,80826,33433,79335,05433,95634,33335,514
       Other Current Assets 
7,073
8,159
8,431
8,037
9,949
6,851
6,554
6,869
7,277
7,906
8,452
9,006
9,500
9,900
9,900
10,400
11,000
11,500
12,300
12,600
13,300
13,600
14,000
14,200
15,200
16,000
16,300
104,600
116,400
116,400104,60016,30016,00015,20014,20014,00013,60013,30012,60012,30011,50011,00010,4009,9009,9009,5009,0068,4527,9067,2776,8696,5546,8519,9498,0378,4318,1597,073
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
456,230
478,916
474,489
551,900
566,900
541,000
550,200
624,200
648,300
670,800
692,000
719,000
783,800
804,600
837,100
937,100
959,100
964,300
996,600
1,005,300
1,005,300996,600964,300959,100937,100837,100804,600783,800719,000692,000670,800648,300624,200550,200541,000566,900551,900474,489478,916456,230000000000
       Property Plant Equipment 
46,266
65,279
75,878
88,491
107,864
153,029
197,564
229,433
258,379
307,891
342,045
368,055
415,500
412,400
423,200
449,200
493,600
497,900
505,500
515,400
546,400
538,200
535,800
553,100
599,900
596,600
601,500
649,200
664,900
664,900649,200601,500596,600599,900553,100535,800538,200546,400515,400505,500497,900493,600449,200423,200412,400415,500368,055342,045307,891258,379229,433197,564153,029107,86488,49175,87865,27946,266
       Goodwill 
39,677
39,697
39,759
39,854
39,840
39,773
39,731
39,774
39,646
39,694
39,739
39,713
39,800
39,600
39,600
39,700
39,800
39,800
39,900
39,800
39,800
51,800
51,800
51,600
51,700
51,700
51,700
51,700
51,700
51,70051,70051,70051,70051,70051,60051,80051,80039,80039,80039,90039,80039,80039,70039,60039,60039,80039,71339,73939,69439,64639,77439,73139,77339,84039,85439,75939,69739,677
       Long Term Investments 
0
0
0
0
125,549
164,117
156,060
145,539
140,784
76,789
62,677
31,006
58,400
60,800
23,500
500
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000050023,50060,80058,40031,00662,67776,789140,784145,539156,060164,117125,5490000
       Intangible Assets 
528
2,208
3,386
4,369
4,351
4,570
5,747
7,791
10,383
11,484
13,040
12,834
13,200
12,400
10,900
10,400
28,700
29,700
33,400
37,200
36,600
52,800
55,100
53,700
75,500
100,200
99,500
99,500
98,700
98,70099,50099,500100,20075,50053,70055,10052,80036,60037,20033,40029,70028,70010,40010,90012,40013,20012,83413,04011,48410,3837,7915,7474,5704,3514,3693,3862,208528
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
3,161
29,435
35,071
41,100
41,700
43,800
50,400
77,000
80,900
92,000
99,600
106,100
141,000
161,900
178,700
210,000
210,600
211,600
196,200
190,000
190,000196,200211,600210,600210,000178,700161,900141,000106,10099,60092,00080,90077,00050,40043,80041,70041,10035,07129,4353,161000000000
> Total Liabilities 
393,497
381,372
394,602
426,094
658,228
659,195
659,708
688,377
716,645
728,982
727,943
1,117,822
1,067,000
1,049,200
1,063,400
1,115,600
1,269,300
1,254,800
1,464,600
1,501,000
1,492,500
1,622,500
1,691,300
1,738,200
1,774,700
1,786,300
1,831,900
1,860,200
1,855,500
1,855,5001,860,2001,831,9001,786,3001,774,7001,738,2001,691,3001,622,5001,492,5001,501,0001,464,6001,254,8001,269,3001,115,6001,063,4001,049,2001,067,0001,117,822727,943728,982716,645688,377659,708659,195658,228426,094394,602381,372393,497
   > Total Current Liabilities 
55,697
39,379
48,018
74,940
86,025
82,414
76,109
97,224
115,657
113,973
105,773
113,282
157,700
130,400
134,400
175,200
207,800
185,500
213,300
228,600
228,800
215,000
279,300
334,200
364,700
383,300
425,000
451,400
451,200
451,200451,400425,000383,300364,700334,200279,300215,000228,800228,600213,300185,500207,800175,200134,400130,400157,700113,282105,773113,973115,65797,22476,10982,41486,02574,94048,01839,37955,697
       Short-term Debt 
269
0
340,836
344,953
566,173
3,451
577,119
0
0
2,315
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000002,31500577,1193,451566,173344,953340,8360269
       Short Long Term Debt 
269
0
340,836
344,953
566,173
3,451
577,119
0
0
2,315
0
0
0
0
0
0
15,600
15,700
20,900
28,900
25,100
25,700
26,300
26,900
27,500
27,800
29,200
49,800
49,400
49,40049,80029,20027,80027,50026,90026,30025,70025,10028,90020,90015,70015,6000000002,31500577,1193,451566,173344,953340,8360269
       Accounts payable 
54,119
38,252
12,243
28,648
24,413
33,846
25,191
26,845
25,500
26,833
24,752
21,245
54,500
36,400
35,600
57,000
54,100
59,100
49,300
58,000
37,700
52,200
57,200
62,100
30,800
85,900
107,500
77,800
19,200
19,20077,800107,50085,90030,80062,10057,20052,20037,70058,00049,30059,10054,10057,00035,60036,40054,50021,24524,75226,83325,50026,84525,19133,84624,41328,64812,24338,25254,119
       Other Current Liabilities 
1,309
1,127
10,116
8,999
10,677
10,660
17,285
24,061
21,205
22,842
24,868
23,358
22,800
25,600
47,300
45,300
35,800
33,400
8,600
37,700
43,500
34,900
67,500
89,600
109,800
92,600
84,800
47,300
68,800
68,80047,30084,80092,600109,80089,60067,50034,90043,50037,7008,60033,40035,80045,30047,30025,60022,80023,35824,86822,84221,20524,06117,28510,66010,6778,99910,1161,1271,309
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
615,009
622,170
1,004,540
909,300
918,800
929,000
940,400
1,061,500
1,069,300
1,251,300
1,272,400
1,263,700
1,407,500
1,412,000
1,404,000
1,410,000
1,403,000
1,406,900
1,408,800
1,404,300
1,404,3001,408,8001,406,9001,403,0001,410,0001,404,0001,412,0001,407,5001,263,7001,272,4001,251,3001,069,3001,061,500940,400929,000918,800909,3001,004,540622,170615,009000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,600
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000004,600000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
15,408
14,819
18,769
21,400
19,800
18,800
18,900
17,800
17,700
16,100
15,400
14,900
17,000
26,800
24,200
35,700
34,200
38,300
38,200
37,900
37,90038,20038,30034,20035,70024,20026,80017,00014,90015,40016,10017,70017,80018,90018,80019,80021,40018,76914,81915,408000000000
       Deferred Long Term Liability 
0
0
0
0
0
14,442
15,475
15,570
15,988
17,211
18,183
19,282
19,900
20,600
19,700
20,700
21,900
22,800
24,400
24,300
26,100
26,600
27,800
28,200
31,300
33,000
33,100
0
0
0033,10033,00031,30028,20027,80026,60026,10024,30024,40022,80021,90020,70019,70020,60019,90019,28218,18317,21115,98815,57015,47514,44200000
> Total Stockholder Equity
63,150
63,585
64,725
74,254
158,516
170,568
179,148
197,929
212,099
223,630
249,780
150,568
75,900
59,000
563,300
595,000
603,600
585,300
459,100
497,900
556,300
446,700
422,400
428,000
476,400
502,800
553,900
607,500
732,700
732,700607,500553,900502,800476,400428,000422,400446,700556,300497,900459,100585,300603,600595,000563,30059,00075,900150,568249,780223,630212,099197,929179,148170,568158,51674,25464,72563,58563,150
   Common Stock
57
58
58
58
58
59
59
59
59
60
60
62
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
0
0
00100100100100100100100100100100100100100100100626060595959595858585857
   Retained Earnings Total Equity00000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000
   Capital Surplus 00000000000000000000000000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
-726
-657
-529
-123
-493
-1,536
-2,386
-2,452
-2,905
-3,085
-2,829
-4,652
-1,200
-3,800
-3,600
-600
5,500
3,200
700
-3,400
-2,200
12,200
7,200
6,800
20,000
15,900
16,300
0
0
0016,30015,90020,0006,8007,20012,200-2,200-3,4007003,2005,500-600-3,600-3,800-1,200-4,652-2,829-3,085-2,905-2,452-2,386-1,536-493-123-529-657-726



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,697,100
Cost of Revenue-537,200
Gross Profit1,159,9001,159,900
 
Operating Income (+$)
Gross Profit1,159,900
Operating Expense-1,477,100
Operating Income220,000-317,200
 
Operating Expense (+$)
Research Development205,000
Selling General Administrative734,900
Selling And Marketing Expenses-
Operating Expense1,477,100939,900
 
Net Interest Income (+$)
Interest Income28,600
Interest Expense-36,200
Other Finance Cost-0
Net Interest Income-7,600
 
Pretax Income (+$)
Operating Income220,000
Net Interest Income-7,600
Other Non-Operating Income Expenses-
Income Before Tax (EBT)214,600217,800
EBIT - interestExpense = -36,200
206,300
242,500
Interest Expense36,200
Earnings Before Interest and Taxes (EBIT)-250,800
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax214,600
Tax Provision-8,300
Net Income From Continuing Ops206,300206,300
Net Income206,300
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net2,2007,600
 

Technical Analysis of Insulet
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Insulet. The general trend of Insulet is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Insulet's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Insulet Corporation.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 172.15 < 173.95 < 182.60.

The bearish price targets are: 141.55 > 138.25 > 121.15.

Tweet this
Insulet Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Insulet Corporation. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Insulet Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Insulet Corporation.

Insulet Corporation Daily Moving Average Convergence/Divergence (MACD) ChartInsulet Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Insulet Corporation. The current adx is .

Insulet Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Insulet Corporation.

Insulet Corporation Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Insulet Corporation.

Insulet Corporation Daily Relative Strength Index (RSI) ChartInsulet Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Insulet Corporation.

Insulet Corporation Daily Stochastic Oscillator ChartInsulet Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Insulet Corporation.

Insulet Corporation Daily Commodity Channel Index (CCI) ChartInsulet Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Insulet Corporation.

Insulet Corporation Daily Chande Momentum Oscillator (CMO) ChartInsulet Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Insulet Corporation.

Insulet Corporation Daily Williams %R ChartInsulet Corporation Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Insulet Corporation.

Insulet Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Insulet Corporation.

Insulet Corporation Daily Average True Range (ATR) ChartInsulet Corporation Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Insulet Corporation.

Insulet Corporation Daily On-Balance Volume (OBV) ChartInsulet Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Insulet Corporation.

Insulet Corporation Daily Money Flow Index (MFI) ChartInsulet Corporation Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Insulet Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-29 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-02 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-16 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-22 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-24 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-26 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-30 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-31 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-07 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-14 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-15 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-28 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-30 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-06 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-07 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-10 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-13 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-15 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-16 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

Insulet Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Insulet Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose169.900
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Insulet with someone you think should read this too:
  • Are you bullish or bearish on Insulet? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Insulet? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Insulet Corporation

I send you an email if I find something interesting about Insulet Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about Insulet Corporation.

Receive notifications about Insulet Corporation in your mailbox!